Navigation Links
ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
Date:5/11/2011

nts with known risk factors for thrombotic events. With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, theoretically, the CJD agent. The risk has been reduced by screening donors for prior exposure to certain virus infections and by manufacturing steps to reduce the risk of viral transmission including pasteurization and nanofiltration. The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials.

Cinryze is for intravenous use only. A dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Enhanze™ Technology

Enhanze™ technology is a proprietary drug delivery platform using Halozyme's first approved enzyme, recombinant human hyaluronidase or rHuPH20. When formulated with other injectable drugs, Enhanze technology can facilitate the subcutaneous dispersion and absorption of these drugs. Molecules as large as 200 nanometers may pass freely through the extracellular matrix, which recovers its normal density within approximately 24 hours, leading to a drug delivery platform which does not permanently alter the architecture of the skin. The principal focus of Halozyme's Enhanze technology platform is the use of rHuPH20 to facilitate subcutaneous administration for large molecule biological therapeutics, some of which currently require intravenous administration. Halozyme has Enhanze partnerships with Roche to apply the technology to Roche's biological therapeutics, including Herceptin® and MabThera®, for up to eight targets, and with Baxter for immunoglobulin.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-thre
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...  Flagship Ventures, a leading venture capital and ... today announced the appointment of Stephane ... this role, Mr. Bancel will provide strategic counsel ... addition to working closely with companies in the ... and Chief Executive Officer of Moderna Therapeutics, a ...
(Date:5/22/2013)...  Grifols, a global healthcare company based in ... study demonstrating that a higher dose of PROLASTIN © ... the alpha 1 protein in patients with alpha ... within the normal range for healthy individuals. AAT deficiency ... of the alpha 1 proteinase inhibitor (A1PI) protein ...
(Date:5/22/2013)... 2013  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical ... unmet medical needs, today announced the appointment of ... its Board of Directors. Dr. Almenoff has extensive experience ... stage drug development. "We are delighted ... Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous ...
Breaking Medicine Technology:Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... N.Y., Sept. 15 Sono-Tek Corporation (OTC Bulletin Board: ... at the symposium of advanced coating technologies, whose aim ... on coating science and technology.  The symposium was attended ... medical and energy projects and by academia from around ...
... U.S. Food and Drug Administration is notifying health care ... tablets and solution used by children and adolescents receiving ... to prevent drug overdosing of children with low body ... creatinine. The revised dosing instructions now appear in the ...
Cached Medicine Technology:Sono-Tek Presents at the 15th International Coating Science and Technology Symposium (ISCST, St. Paul, MN) 2FDA Issues New Dosing Guide for Children Using Valcyte 2
(Date:5/22/2013)... Texas (PRWEB) May 22, 2013 Beginning ... On” in the Conrad Foundation’s Spirit of Innovation ... and technical plan competition, free and open to students ... , The Spirit of Innovation Challenge celebrates the life ... to walk on the Moon. The program challenges teens ...
(Date:5/22/2013)... Rye Brook, New York (PRWEB) May 22, 2013 ... clinic that specializes in combining treatments for optimal results, ... thicken thin skin on the neck. The practice ... and seen dramatic results. , “Basically, this approach is ... neck lift,” says Westchester dermatologist Dr. Michelle ...
(Date:5/22/2013)... JoVE will publish details of a ... relation to a patients age. The method is demonstrated by ... Einstein College of Medicine. Dr. Atzmon hopes that the dissemination ... genetic thermometer to assess a patients health in relation to ... publication will feature a technique that measures telomere length. ...
(Date:5/22/2013)... GA (PRWEB) May 22, 2013 ... agency, JD Media Surge, LLC, E-Dentists.com has launched ... The blog will feature numerous topics of interest ... treatment options and dental health. , http://www.E-Dentists.com/Blog/ ... of dental Internet marketing. In addition to addressing ...
(Date:5/22/2013)... May 2013, Paris, France: Results from a ... today question whether bivalirudin is superior to ... showing similar 30-day mortality in patients with ... undergoing percutaneous coronary intervention (PCI)., European and ... as an alternative to unfractionated heparin plus ...
Breaking Medicine News(10 mins):Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:How healthy are you for your age? 2Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Registry questions superiority of bivalirudin over heparin 2
... the perfect night,s sleepDALLAS, April 7 ... a free-standing, patent pending kiosk that contains all of the ... product breaks the mold for the industry standards of soft, ... an individual,s sleep preference of side, back or stomach sleeper. ...
... strategic analysis of technologies. , ... Atlanta, GA ... global leader in legal consulting, technology and outsourcing, today announced it ... vendor of software tools that enable rapid comprehension and decision making ...
... of anti-aging injections continue, as do false claims and risk ... ... Physicians Coalition for Injectable Safety , There is no debating ... themselves, particularly in appearance enhancing treatments that restore youth and erase ...
... traits of wisdom appear to follow a universal path ... -- Wisdom appears to be more than a subjective ... circuits and pathways, suggest U.S. researchers who compiled the ... this type of research could potentially lead to interventions ...
... therapy, household changes added 3.5 years on average, study ... home-based program for seniors that includes occupational and physical ... help people live longer, new research found. , In ... 3.5 years of lifespan compared to those who didn,t, ...
... Community Hospice of Northeast Florida , in collaboration ... across the country to complete their advance healthcare directives ... designation of April 16, 2009 ... recent gains in public awareness of the need for ...
Cached Medicine News:Health News:Now Available Online, The Pillow Bar is the Right Mix of Luxury and Necessity 2Health News:UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics 2Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 2Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 3Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 4Health News:Pathway to Wisdom May Be Found in Brain Circuitry 2Health News:Home-Based Program Extends Seniors' Lives 2Health News:Home-Based Program Extends Seniors' Lives 3Health News:Community Hospice Supports National Healthcare Decisions Day 2Health News:Community Hospice Supports National Healthcare Decisions Day 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: